Skip to main content

EN
ÍS

Forsíða

Forsíða

Þórdís Jóna Hrafnkelsdóttir - Dósent

Þórdís Jóna Hrafnkelsdóttir

–

Heilbrigðisvísindasvið

Þórdís Jóna Hrafnkelsdóttir

Dósent

Kennslustjóri Læknadeildar

Sími
8245762 8245762
Tölvupóstur
tjonah [hjá] hi.is

Starfseining
Læknadeild

ORCID vefsíða
https://orcid.org/0000-0002-4398-2898
Rannsóknagátt – Þórdís Jóna Hrafnkelsdóttir

Útgefið efni

2023

2023 ESC Guidelines for the management of endocarditis.European heart journal
Lifetime exposure to violence and early cardiometabolic risk factors in a healthy Swedish cohort

2022

[Cardiac transplantation and donation in Icelandic patients - indications and outcome]Laeknabladid
Improving outpatient care for heart failure through digital innovation: a feasibility study.Pilot and feasibility studies
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.European heart journal
European Society of Cardiology: cardiovascular disease statistics 2021European heart journal

2020

The Establishment of the Nordic Cardio-Oncology Society.JACC. CardioOncology
Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer.Current heart failure reports

2019

Roadmap for cardiovascular education across the European Society of Cardiology: Inspiring better knowledge and skills, now and for the futureEuropean Heart Journal

2018

[Outcome of coronary artery bypass grafting in women in Iceland].Laeknabladid

2015

2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).European heart journal

2014

Profibrinolytic effect of the epigenetic modifier valproic acid in manPLoS ONE

2013

Acute vascular effects of atorvastatin in hypertensive men: A pilot studyScandinavian Cardiovascular Journal

2011

[Aortic valve replacement therapy - a new approach to come?].,Osædarlokusipti -- á leid inn í nýja tíma?Læknabladid
The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure loweringJournal of Thrombosis and Thrombolysis
Ósæarlokuskipti - á lei inn í nýja tíma?Laeknabladid

2010

Response to letter to editor by Jolobe 'Results have relevance for resolving discrepancies in the approach to population screening'Journal of Internal Medicine
Transcutaneous electrical nerve stimulation induces vasodilation in healthy controls but not in refractory angina patientsJournal of Pain and Symptom Management
Consistency of blood pressure and impact on cardiovascular structure over 20 years in young menJournal of Internal Medicine

2007

ST segment elevation and chest pain during cryoablation of atrial flutterEuropace
Local tissue-type plasminogen activator release in patients with ischemic stroke [1]Journal of Thrombosis and Haemostasis

2006

TNF-α mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-κB- and p38 MAPK-dependentJournal of Thrombosis and Haemostasis
Impaired capacity for stimulated fibrinolysis in primary hypertension is restored by antihypertensive therapyHypertension

2005

Prolonged cyclic strain impairs the fibrinolytic system in cultured vascular endothelial cellsJournal of Hypertension

2004

Regulation of local availability of active tissue-type plasminogen activator in vivo in manJournal of Thrombosis and Haemostasis
Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertensionHypertension

2003

Fibrinolytic capacity increases with age in healthy humans, while endothelium-dependent vasodilation is unaffectedThrombosis and Haemostasis

2001

Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in manThrombosis and Haemostasis

2000

Forearm blood flow responses to neuropeptide Y, noradrenaline and adenosine 5'-triphosphate in hypertensive and normotensive subjectsBlood Pressure
Elevated intraluminal pressure inhibits vascular tissue plasminogen activator secretion and downregulates its gene expressionHypertension

1999

Desmopressin-induced release of Tissue-Type Plasminogen Activator (t-PA) in human forearm is not influenced by nitric oxide synthesis inhibitionFibrinolysis and Proteolysis

1998

Impaired capacity for endogenous fibrinolysis in essential hypertensionLancet
Impaired release of tissue-type plasminogen activator (t-PA) from vascular endothelium in essential hypertensionFibrinolysis and Proteolysis

Sérsvið:

Hjarta- og æðasjúkdómar